Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Cohen

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Cell Death & Disease|January 11, 2022
RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasisYongsheng Huang, Sijia Liu, Mengjie Shan, et al.
International Journal of Cancer|January 5, 2020
The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancerKiki M H Vangangelt, Andrew R Green, Isabelle M F Heemskerk, et al.
Clinical Lung Cancer|August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Cancer Cytopathology|April 2, 2024
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter studySandra N Freiberger, Kristian Ikenberg, Demi van Egmond, et al.
International Journal of Cancer|May 27, 2021
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancerSophie C Hagenaars, Stefanie de Groot, Danielle Cohen, et al.
JTO Clinical and Research Reports|December 1, 2021
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLCLiesbeth M Hondelink, Merel Jebbink, Jan H von der Thüsen, et al.
The Journal of Pathology. Clinical Research|February 23, 2021
Variability in grading of ductal carcinoma in situ among an international group of pathologistsMaartje van Seijen, Katarzyna Jóźwiak, Sarah E Pinder, et al.
Life (Basel, Switzerland)|March 25, 2022
Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic ReviewLisanne K A Neijenhuis, Lysanne D A N de Myunck, Okker D Bijlstra, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Cell Death & Disease|January 11, 2022
RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasisYongsheng Huang, Sijia Liu, Mengjie Shan, et al.
International Journal of Cancer|January 5, 2020
The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancerKiki M H Vangangelt, Andrew R Green, Isabelle M F Heemskerk, et al.
Clinical Lung Cancer|August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Cancer Cytopathology|April 2, 2024
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter studySandra N Freiberger, Kristian Ikenberg, Demi van Egmond, et al.
International Journal of Cancer|May 27, 2021
Tumor-stroma ratio is associated with Miller-Payne score and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancerSophie C Hagenaars, Stefanie de Groot, Danielle Cohen, et al.
JTO Clinical and Research Reports|December 1, 2021
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLCLiesbeth M Hondelink, Merel Jebbink, Jan H von der Thüsen, et al.
The Journal of Pathology. Clinical Research|February 23, 2021
Variability in grading of ductal carcinoma in situ among an international group of pathologistsMaartje van Seijen, Katarzyna Jóźwiak, Sarah E Pinder, et al.
Life (Basel, Switzerland)|March 25, 2022
Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic ReviewLisanne K A Neijenhuis, Lysanne D A N de Myunck, Okker D Bijlstra, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysisLiesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Pageof 8